Effect of four oral contraceptives on hemostatic parameters
- 31 August 2004
- journal article
- clinical trial
- Published by Elsevier BV in Contraception
- Vol. 70 (2), 97-106
- https://doi.org/10.1016/j.contraception.2004.03.004
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisBlood, 2003
- Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over studyThe Lancet, 1999
- Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptivesBritish Journal of Haematology, 1997
- The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptivesBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiolContraception, 1996
- Ethinylestradiol 20 versus 30 μg combined with 150 μg desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic systemGynecological Endocrinology, 1996
- The risk of venous thromboembolism associated with low oestrogen oral contraceptivesJournal of Obstetrics and Gynaecology, 1995
- Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.BMJ, 1993
- Steroidal contraceptives and changes in individual plasma phospholipids: possible role in thrombosisAdvances in Contraception, 1990
- A comparison of the effects of two triphasic oral contraceptives on haemostasisBritish Journal of Haematology, 1988